标题
Angiogenesis in melanoma: an update with a focus on current targeted therapies
作者
关键词
-
出版物
JOURNAL OF CLINICAL PATHOLOGY
Volume 69, Issue 6, Pages 472-483
出版商
BMJ
发表日期
2016-02-11
DOI
10.1136/jclinpath-2015-203482
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Microvessel density, lymphovascular density, and lymphovascular invasion in primary cutaneous melanoma—correlation with histopathologic prognosticators and BRAF status
- (2015) Phyu Phyu Aung et al. HUMAN PATHOLOGY
- miR-214 as a Key Hub that Controls Cancer Networks: Small Player, Multiple Functions
- (2015) Elisa Penna et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
- (2015) Jeffrey S Weber et al. LANCET ONCOLOGY
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Vessel Normalization by Chloroquine Independent of Autophagy
- (2014) Hannelore Maes et al. CANCER CELL
- Postsurgical Adjuvant Tumor Therapy by Combining Anti-Angiopoietin-2 and Metronomic Chemotherapy Limits Metastatic Growth
- (2014) Kshitij Srivastava et al. CANCER CELL
- Monocyte Subpopulations in Angiogenesis
- (2014) H. J. Dalton et al. CANCER RESEARCH
- Angiogenesis, vasculogenic mimicry and vascular invasion in cutaneous malignant melanoma – implications for therapeutic strategies and targeted therapies
- (2014) Hye Jin Chung et al. Expert Review of Anticancer Therapy
- Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study
- (2014) Pippa G Corrie et al. LANCET ONCOLOGY
- Metronomics: towards personalized chemotherapy?
- (2014) Nicolas André et al. Nature Reviews Clinical Oncology
- Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
- (2014) F. S. Hodi et al. Cancer Immunology Research
- A pilot Phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma
- (2014) Giorgio Parmiani et al. OncoImmunology
- NGR-TNF, a novel vascular-targeting agent, does not induce cytokine recruitment of proangiogenic bone marrow-derived cells
- (2013) P Di Matteo et al. BRITISH JOURNAL OF CANCER
- Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta-analysis
- (2013) I. Pastushenko et al. BRITISH JOURNAL OF DERMATOLOGY
- Angiopoietin-2: An Attractive Target for Improved Antiangiogenic Tumor Therapy
- (2013) D. Gerald et al. CANCER RESEARCH
- Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)
- (2013) C. L. Slingluff et al. CLINICAL CANCER RESEARCH
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vascular Normalization as a Therapeutic Strategy for Malignant and Nonmalignant Disease
- (2013) S. Goel et al. Cold Spring Harbor Perspectives in Medicine
- Highly Invasive Melanoma Cells Activate the Vascular Endothelium via an MMP-2/Integrin αvβ5–Induced Secretion of VEGF-A
- (2012) Anna Desch et al. AMERICAN JOURNAL OF PATHOLOGY
- Tumor Cell Vasculogenic Mimicry
- (2012) Richard E.B. Seftor et al. AMERICAN JOURNAL OF PATHOLOGY
- A decreased ratio between serum levels of the antagonistic angiopoietins 1 and 2 indicates tumour progression of malignant melanoma
- (2012) Masyar Gardizi et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Convergent Multi-miRNA Targeting of ApoE Drives LRP1/LRP8-Dependent Melanoma Metastasis and Angiogenesis
- (2012) Nora Pencheva et al. CELL
- The involvement of Notch signaling in melanoma vasculogenic mimicry
- (2012) Amalia Vartanian et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasis
- (2012) Ramin Shayan et al. HISTOPATHOLOGY
- Phase III Trial of Carboplatin and Paclitaxel With or Without Sorafenib in Metastatic Melanoma
- (2012) Keith T. Flaherty et al. JOURNAL OF CLINICAL ONCOLOGY
- The Immunocytokine L19–IL2 Eradicates Cancer When Used in Combination with CTLA-4 Blockade or with L19-TNF
- (2012) Kathrin Schwager et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Functional Screen Identifies Specific MicroRNAs Capable of Inhibiting Human Melanoma Cell Viability
- (2012) Jos B. Poell et al. PLoS One
- Differentiation and gene expression profile of tumor-associated macrophages
- (2012) Astrid Schmieder et al. SEMINARS IN CANCER BIOLOGY
- Clinical Relevance of Detection of Lymphovascular Invasion in Primary Melanoma Using Endothelial Markers D2-40 and CD34
- (2011) Amy E. Rose et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma
- (2011) S O'Day et al. BRITISH JOURNAL OF CANCER
- Multicenter, Phase II Study of Axitinib, a Selective Second-Generation Inhibitor of Vascular Endothelial Growth Factor Receptors 1, 2, and 3, in Patients with Metastatic Melanoma
- (2011) J. Fruehauf et al. CLINICAL CANCER RESEARCH
- MicroRNA-mediated regulation of the angiogenic switch
- (2011) Sudarshan Anand et al. CURRENT OPINION IN HEMATOLOGY
- Semaphorin-PlexinD1 Signaling Limits Angiogenic Potential via the VEGF Decoy Receptor sFlt1
- (2011) Tomasz Zygmunt et al. DEVELOPMENTAL CELL
- Semaphorin 3E-Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism
- (2011) J. Kim et al. GENES & DEVELOPMENT
- BEAM: A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Melanoma
- (2011) Kevin B. Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent
- (2011) Robert L. Hudkins et al. JOURNAL OF MEDICINAL CHEMISTRY
- Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma
- (2011) Sarah J Storr et al. MODERN PATHOLOGY
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma
- (2010) Peter Hersey et al. CANCER
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Vascular microRNAs
- (2010) Angelika Bonauer et al. CURRENT DRUG TARGETS
- The Notch signaling pathway: Molecular basis of cell context dependency
- (2010) Ralf Schwanbeck et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Cancer and Inflammation: Promise for Biologic Therapy
- (2010) Sandra Demaria et al. JOURNAL OF IMMUNOTHERAPY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion
- (2009) S Singh et al. BRITISH JOURNAL OF CANCER
- Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface
- (2009) Tania M. Hansen et al. CELLULAR SIGNALLING
- Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases
- (2009) R. K. Amaravadi et al. CLINICAL CANCER RESEARCH
- Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant Melanoma
- (2009) I. Helfrich et al. CLINICAL CANCER RESEARCH
- AngiomiRs—Key regulators of angiogenesis
- (2009) Shusheng Wang et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression
- (2009) Chiara Gabellini et al. EUROPEAN JOURNAL OF CANCER
- Cancer associated fibroblasts (CAFs) in tumor microenvironment
- (2009) Fei Xing Frontiers in Bioscience-Landmark
- Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma
- (2009) Matthew Petitt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Real-time imaging reveals the single steps of brain metastasis formation
- (2009) Yvonne Kienast et al. NATURE MEDICINE
- MicroRNAs: Opening a New Vein in Angiogenesis Research
- (2009) J. E. Fish et al. Science Signaling
- Cancer associated fibroblasts in cancer pathogenesis
- (2009) Omar E. Franco et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma
- (2008) Domingo G. Perez et al. CANCER
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
- (2008) Rose Du et al. CANCER CELL
- Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF
- (2008) I Depasquale et al. HISTOPATHOLOGY
- Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis
- (2008) Xiaowei Xu et al. HUMAN PATHOLOGY
- Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability
- (2008) Christopher A Jones et al. NATURE MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started